文献速递瘢痕与激光烧伤

二氧化碳激光治疗烧伤相关瘢痕:ELIPSE(早期激光干预促进瘢痕演变)前瞻性随机对照试验结果

Carbon dioxide laser treatment of burn-related scarring: Results of the ELIPSE (Early Laser Intervention Promotes Scar Evolution) prospective randomized controlled trial.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-06-19

该前瞻性随机对照试验纳入15例成人烧伤相关瘢痕患者,采用自身对照设计,将瘢痕随机分为治疗组(接受3次点阵二氧化碳激光治疗,间隔6周)和对照组。结果显示两组在温哥华瘢痕量表(VSS)、红斑或色素沉着方面无显著差异,但激光组在患者观察者瘢痕评估量表(POSAS)的厚度和质地方面改善,盲法照片评估评分更优,RNA测序提示激光诱导成纤维细胞基因表达持续改变。

要点

  • 点阵二氧化碳激光治疗组与对照组在VSS、红斑和色素沉着方面无显著差异。
  • 激光组POSAS瘢痕厚度和质地改善,盲法照片评估评分优于对照组。
  • RNA测序提示激光治疗改变成纤维细胞转录组至少持续3个月。

核心结论

  • 点阵二氧化碳激光治疗的瘢痕在激光后6个月时厚度和质地显著改变,3次治疗后盲法照片分析评分优于对照组。
  • RNA测序结果提示激光治疗改变治疗成纤维细胞的转录组至少持续至治疗后3个月。
  • 作者认为将该研究扩展以更深入研究成纤维细胞对激光的反应以及评估对日常活动和生活质量的影响将是有益的。

研究设计与样本

  • 前瞻性随机对照试验,纳入15例成人烧伤相关瘢痕患者,所有参与者作为自身对照。
  • 纳入标准为两个不相邻的瘢痕区域各占1%总体表面积、基线温哥华瘢痕量表(VSS)评分相似且伤后3个月。
  • 瘢痕随机分为治疗组或对照组,治疗组接受3次点阵二氧化碳激光治疗,间隔6周。
  • 结局指标在基线、治疗后3、6和12个月记录,包括盲法VSS、患者观察者瘢痕评估量表(POSAS)、Brisbane烧伤瘢痕影响概况(BBSIP)、盲法瘢痕照片评估、组织学分析和RNA测序分析。

主要发现

  • VSS、瘢痕红斑或色素沉着方面未发现显著差异。
  • 点阵二氧化碳激光治疗后患者POSAS在瘢痕厚度和质地方面改善。
  • BBSIP所有要素在对照组和激光组均改善。
  • 盲法评估者给点阵二氧化碳激光治疗瘢痕的评分优于对照瘢痕。
  • RNA测序显示点阵二氧化碳激光诱导成纤维细胞基因表达的持续改变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To investigate the impact of ablative fractional carbon dioxide laser (AFCO2L) on patient-reported outcomes measures, subjective scar appearance, dermal architecture, and gene transcription in early burn scars. METHODS: Fifteen adult patients with a burn-related scar were recruited. Inclusion criteria were two non-contiguous scar areas of 1% total body surface area, similar baseline Vancouver scar scale (VSS) score and 3months since the time of injury. All participants acted as their own control. Scars were randomized to treatment or control. Treatment scars received three AFCO2L treatments at 6-week intervals. Outcome measures were recorded at baseline, 3, 6, and 12-months post-treatment. Measures included blinded VSS, Patient Observer Scar Assessment Scale (POSAS), Brisbane Burn Scar Impact Profile (BBSIP), blinded scar photo assessment, histological tissue analysis, and RNA sequencing analysis. RESULTS: No significant difference was found in VSS, scar erythema, or pigmentation. Patient POSAS improved in scar thickness and texture following AFCO2L. All elements of BBSIP improved in control and laser groups. AFCO2L-treated scars were scored better than control scars by blinded raters. RNA sequencing illustrated that AFCO2L induced sustained changes in fibroblast gene expression. CONCLUSIONS: AFCO2L treated scars had significantly altered scar thickness and texture 6 months post-laser and were rated better than controls on blinded photo analysis after 3 treatments. RNASeq results suggest laser treatment alters the transcriptome of treated fibroblasts for at least 3 months after treatment. Expansion of this research to study in more depth fibroblast changes in response to laser, as well as assessing the impact on daily activity and quality of life, will be beneficial.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Lewis CJ, Douglas H, Martin L, et al. Carbon dioxide laser treatment of burn-related scarring: Results of the ELIPSE (Early Laser Intervention Promotes Scar Evolution) prospective randomized controlled trial. J Plast Reconstr Aesthet Surg. 2023. PMID: 37393760. doi:10.1016/j.bjps.2023.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。